Onkologie. 2012:6(1):31-34

The late side effects of the cancer treatment of the long - term survivors

Hana Šiffnerová
Onkologické oddělení Nemocnice České Budějovice

The treatment of cancer is often linked with the occurrence of unwanted side effects, the most serious of which are the late effects. They

can develop after chemotherapy, hormonotherapy, but especially after radiotherapy. It is still too early to evaluate the side effects of

biological treatment more deeply. The late side effects of the treatment occur at long-term survivors, they are mostly difficult to solve

and make the quality of life worse.

Keywords: late unwanted effects, chemotherapy, radiotherapy, second cancer

Published: February 29, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šiffnerová H. The late side effects of the cancer treatment of the long - term survivors. Onkologie. 2012;6(1):31-34.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol 2011; 50(2): 187-193. Go to original source... Go to PubMed...
    2. Klener P. Klinická onkologie, 1. vydání, Galen 2002: 213-276.
    3. Smith RE, Bryant J, Delicillis A, Anderson S. Acute myeloid leukemia and myedisplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol 2003; 21(7): 1195. Go to original source... Go to PubMed...
    4. Ganz PA, et al. Late effects of cancer in adult survivors: What are they and what is the oncologist's role in follow-up and prevention? Am Soc Clin Oncol 2005: 724-730.
    5. Travis LB. Therapy-associated solid tumors. Acta oncologica 2002; 41: 323-333. Go to original source... Go to PubMed...
    6. Vaughn DJ, Gignac GA, Meadows AT. Long-term medical care of testicular cancer survivors. Ann Intern Med 2002; 136: 463-470. Go to original source... Go to PubMed...
    7. Boyer M, Raghavan D. Toxicity of treatment of germ cell tumors. Seminars in Oncology 1992; 19: 128-142.
    8. Adam Z, Vorlíček J, Táborská E, et al. Protinádorová chemoterapie. In Adam Z, Vorlíček J, Koptíková J. Obecná onkologie a podpůrná léčba, 1. vydání, Grada Publishing 2003: 295-355.
    9. Petera J, Odrážka K, Zounar M, et al. Účinek záření na zdravé tkáně. In. Šlampa P, Petera J. Radiační onkologie, 1. vydání, Galén 2007: 29-33.
    10. Jurga L, et al. Klinická onkológia a rádioterapia, 1. vydání, Slovak Academic Press s.r.o. 2000: 274-307.
    11. Jurga L, et al. Klinická a radiační onkológia, 1. vydání, Osveta Martin 2010: 406-409.
    12. Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. Curr Probl Cancer 2010; 34(3): 211-227. Go to original source... Go to PubMed...
    13. Fraumeni JF, Curtis RE, Edwards BK, Tucker MA. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. J Natl Cancer Inst 2007.
    14. Ng AK. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. Br J Haematol 2011; 154(1): 23-31. doi: 10.1111/j.1365-2141.2011.08713.x. Epub 2011 May 3. Go to original source... Go to PubMed...
    15. Zablotska LB, Matasar MJ, Neugut AI. Second malignancies after radiation treatment and chemotherapy for primary cancers. In: Chang AE. Oncology, An Evidence-Based Approach, Springer Science + business Media, Inc 2006: 1929-1940.
    16. Boice JD. Cancer following medical irradiation. Cancer 1981; 47: 1081-1090. Go to original source...
    17. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin´s disease: a population-based evaluation over 25 years. J Clin Oncol 2002; 20: 3484-3494. Go to original source... Go to PubMed...
    18. Van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin´s disease. J Natl Cancer Inst 2003; 95(13): 971. Go to original source... Go to PubMed...
    19. Anscher MS. Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 2010; 15(4): 350-359. Go to original source... Go to PubMed...
    20. Ganz PA. Harnessing personalized medicine to prevent late effects. Lancet 2010; 11(1): 7-8. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.